Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Fernando Lopes Gonçales Jr"'
Autor:
Luiz Jancintho da Silva, Mariângela R. Resende, William B. de Abreu, Fransisco H. Aoki, Raquel B.S. Bocatto, Maria Luiza Moretti Branchinni, Fernando Lopes Gonçales Jr., Josué N. de Lima, Angela von Nowakonski, Priscila M. O. Papaiordanou, Rogério de Jesus Pedro, Cláudio L. Rossi
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 34, Iss 5, Pp 475-478 (1992)
Listeriosis is a not uncommon infection in humans, usually associated with immunodeficient states and with newborns. However, relatively few cases have been reported in HIV-infected patients. This scarcity of reported cases has aroused interest in th
Externí odkaz:
https://doaj.org/article/ad5c3ab60f0641ed87a1c908cb2edfe1
Autor:
Fernando Lopes GONÇALES Jr., Raquel Silveira Bello STUCCHI, Priscila Maria Oliveira PAPAIORDANOU, Maria Helena Postal PAVAN, Neiva Sellan Lopes GONÇALES, João Renato Rebello PINHO
Publikováno v:
Revista do Instituto de Medicina Tropical de São Paulo, Vol 40, Iss 4, Pp -224 (1998)
The determination of aminotranferases levels is very useful in the diagnosis of hepatopathies. In recent years, an elevated serum ALT level in blood donors has been associated with an increased risk of post-transfusion hepatitis (PTH). The purpose of
Externí odkaz:
https://doaj.org/article/1e7e8d63531b465dbc7f3e265b9a04c7
Autor:
Fernando Lopes Gonçales Jr., Aline Vigani, Neiva Gonçales, Antonio Alci Barone, Evaldo Araújo, Roberto Focaccia, Umbeliana Oliveira, Henrique Sérgio Morais Coelho, Jacqueline Paixao, Renata Perez, Cirley Lobato, Judith Weirich, Heitor Rosa, Andrelina Borges, Ricardo Vila, Maria Lúcia Corrêa-Giannella, Maria Lúcia Gomes Ferraz
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 10, Iss 5, Pp 311-316
Combination therapy with pegylated interferon and ribavirin is considered the new standard therapy for naïve patients with chronic hepatitis C. We evaluated the efficacy and safety of treatment with weight-based peginterferon alpha-2b (1.5 mg/kg per
Externí odkaz:
https://doaj.org/article/bfd8a3f170814546a43f69e91f868b3d
Autor:
Aline Gonzalez Vigani, Eduardo Sellan Gonçales, Maria Helena Postal Pavan, Flavia Genari, Raquel Tozzo, Maria Silvia Kroll Lazarini, Viviane Fais, Adriana Feltrin, Neiva Sellan Gonçales, Fernando Lopes Gonçales Jr
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 16, Iss 3, Pp 232-236
BACKGROUND: Pegylated interferon (Peg-IFN) and standard interferon (IFN) play a significant role in the treatment of hepatitis C virus (HCV) infection. Biosimilar standard IFN is widely available in Brazil for the treatment of HCV infection genotypes
Externí odkaz:
https://doaj.org/article/737a94b84f114d9ca8ab25e2e202fbac
Autor:
Maria Helena Postal Pavan, Elizabeth João Pavin, Fernando Lopes Gonçales Jr, Denise Engelbrecht Zantut-Wittmann
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 15, Iss 5, Pp 449-456
OBJECTIVE: The treatment of the chronic hepatitis C (HCV) with α-interferon is associated with thyroid dysfunction (TD). The aim of this study was to evaluate thyroid function outcome among patients with chronic HCV under treatment with conventional
Externí odkaz:
https://doaj.org/article/f560602e0f3e491aa31349ca344a02db
Autor:
Fernando Lopes Gonçales Jr.
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 11, Iss suppl 1, Pp 50-51
Externí odkaz:
https://doaj.org/article/e64599e2a2ef4f8e96afd290ce703dc4
Autor:
Aline Gonzalez Vigani, Eduardo Sellan Gonçales, Maria Helena Postal Pavan, Flavia Genari, Raquel Tozzo, Maria Silvia Kroll Lazarini, Viviane Fais, Adriana Feltrin, Neiva Sellan Gonçales, Fernando Lopes Gonçales, Jr
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 16, Iss 3, Pp 232-236 (2012)
Background: Pegylated interferon (Peg-IFN) and standard interferon (IFN) play a significant role in the treatment of hepatitis C virus (HCV) infection. Biosimilar standard IFN is widely available in Brazil for the treatment of HCV infection genotypes
Externí odkaz:
https://doaj.org/article/0185ebba05ab490388304908eb8b2bd9
Autor:
Maria Helena Postal Pavan, MSc, MD, Elizabeth João Pavin, PhD, Fernando Lopes Gonçales, Jr, PhD, Denise Engelbrecht Zantut Wittmann, PhD
Publikováno v:
Brazilian Journal of Infectious Diseases, Vol 15, Iss 5, Pp 449-456 (2011)
Objective: The treatment of the chronic hepatitis C (HCV) with α-interferon is associated with thyroid dysfunction (TD). The aim of this study was to evaluate thyroid function outcome among patients with chronic HCV under treatment with conventional
Externí odkaz:
https://doaj.org/article/36c40ee0224e411385fa1b00b2035750